🇺🇸 FDA
Patent

US 11254667

Substituted imidazo[1,2-A]pyridines as IRAK 1/4 and flt3 inhibitors

granted A61PA61P35/00A61P35/02

Quick answer

US patent 11254667 (Substituted imidazo[1,2-A]pyridines as IRAK 1/4 and flt3 inhibitors) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary, Dept. of Health and Human Services
Grant date
Tue Feb 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
38
CPC classes
A61P, A61P35/00, A61P35/02